Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-06-06
1998-11-24
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530329, A61K 3808, C07K 706
Patent
active
058406972
ABSTRACT:
The present invention relates to novel family of peptides which inhibit calmodulin and which have the general structure Ac-A1-B2-C3-D4-E5-F6-NH.sub.2, (SEQ ID No. 1), wherein A1 is (D)Leu or Leu, B2 is (D)Gln, Gln, (D)Trp, or Trp, C3 is (D)Arg, Arg, (D)Ile, or Ile, D4 is (D)Ile, Ile, (D)His, or His, E5 is (D)Leu, Leu, (D)His, or His, and F6 is (D)Trp, Trp, (D)Arg, or Arg. The novel peptides can be used to inhibit the activity of calmodulin. In addition, the present invention relates to pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a calmodulin-inhibitor peptide. These compositions can be used to treat calmodulin related disorders.
REFERENCES:
patent: 2645640 (1953-07-01), Charpentier
patent: 4117118 (1978-09-01), Harri et al.
patent: 4758559 (1988-07-01), Wasley et al.
patent: 5182262 (1993-01-01), Leto
patent: 5340565 (1994-08-01), Pero
patent: 5480903 (1996-01-01), Piggott
patent: 5532337 (1996-07-01), Hayashi et al.
patent: 5624902 (1997-04-01), Blondelle et al.
Hait et al., "The effect of calmodulin inhibitors with bleomycin on the treatment of patients with high grade gliomas." Cancer Res., 6636-6640 (1990).
Hidaka et al., "N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation." Proc. Natl. Acad. Sci. USA, 78(7):4354-4357 (1981).
Polak et al., "A novel calmodulin antagonist, CGS 9343B, modulates calcium-dependent changes in neurite outgrowth and growth cone movements." J. of Neuroscience, 11(2):534-542 (1991).
Sharma and Wang, "Preparation and assay of the Ca.sup.2+ --dependent modulator protein." Advances in Cyclic Nucleotide Res., 10:187-198 (1979).
Schuller et al., "Successful chemotherapy of experimental neuroendocrine lung tumors in hamsters with an antagonist of Ca.sup.2+ /calmodulin." Cancer Res., 50:1645-1649 (1990).
Wallace et al., "Assay of calmodulin by Ca.sup.2+ -dependent phosphodiesterase." Methods in Enzymology, 102:39-47 (1983).
Blondelle Sylvie E.
Houghten Richard A.
Perez-Paya Enrique
Borin Michael
Torrey Pines Institute For Molecular Studies
Tsang Cecilia J.
LandOfFree
Peptide inhibitors of calmodulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide inhibitors of calmodulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide inhibitors of calmodulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1702262